Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial
Study Overview The study investigates the effectiveness of adjunctive therapy using dulaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in patients […]
